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妊娠ラット (妊娠 17-19日目)をペントバルビタール (40-60mg塵 ip)で麻酔 し､37
℃に加温 した0.1%ヒビテン液に浸けて頭部を除 く全身を消毒 した｡次いで､ラットを滅
菌 したバットの上に仰向けにして置き､腹部にイソジンを塗布 した｡下腹部を切開し､腸
管を傷つけないように注意 して結合組織を切 り離 しながら子宮を引きずり出した｡子宮








で保有 した｡実体顕微鏡下に､以下の手順で大脳皮質の切 り出しを行った｡ 脳幹を切 り
落とし､終脳の正中線にそって左右の大脳半球に分けた｡間脳を切 り離 し､次いで､海
馬を含む大脳辺縁系を切 り落とした｡最後に中心部に残った大脳基底核を大脳皮質から












































































































































































































    *-
68kDa-
A













 1 OO ptM
Fig.1-4 The amount of PLC-6 in the cytosolic and membrane fractions in control
   and glutamate-treated cultured cortical neurons.
   Rabbit anti-PLC-6 antibody was used to detect a 85 kDa protein in the cytosolic and
   mambrane fractions of control (non-treated) and glutamate (50 and 100 ptM)- treated
   cultures. A: An example of the Western blot.in the cytosolic fractions of control (O) and 50
   pM glutamate (50)- and 100 pM glutamate (100)-treated clutures is shown. A 85 kDa
   protein band recognized by anti-PLC-6 antibody is shown (*). B: The Western blot was
   quantified by scanning densitometry in the cytosolic and membrane fractions. The PLC-
   6 content in the cytosolic fraction ( 1 ) was significantly increased in the glutamate-
   treated group compared with the control (non-treated) group. The PLC-6 content in the
   membrane fraction ( D ) was not changed in control and glutamate-treated groups. Bars



























































































































































































































































































































































































































Fig. 2·8 BDNF prevented neurotoxicity induced by SNOC(A) and SIN·1 (B).
Cultures were exposed to SNOC (A) or SIN-l (B) for 10 min followed by a 24 hr incubation
with normal medium. BDNF was added for 24 hr prior to application of neurotoxins.
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Fig. 3-3Effects of cycloheximide on the protective action of BDNF (A) and NGF (B).
Cultures were exposed to 100 ptM glutamate for 10 min then incubated for 24 hr with
standard medium. Cultures were pretreated with 60 nglml BD]MF or NGF for 24 hr prior
to the glutamate application. Cycloheximide was added to the neurotrophin-containing








































































Fig. 3-6 Effect of NGF on SIN-1-induced neurotoxicity in primary cortical cultures.
Cultures were exposed to SIN-l for 10 min followed by a 24 hr incubation with normal
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Fig. 3-9Effects of NGF and BDNF on the phospherylation of MAPK in primary
cortical cultures.
A, Cultures were treated with either 60 ng/ml NGF or 60 ng/ml BDNF for the period
indicated. fysates were separated by SDS-PAGE and subjected to immunoblotting with
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セラミド (1叫 M)はグルタミン酸神経毒性を抑制しなかった (Fig･3-12B)0


















































Fig. 3-12Effects of ceramide analogs on glutamate neurotoxicity.
A, C2-ceramide prevents glutamate neurotoxicity in a concentration-dependent manner.
Cultures were exposed to 100 IAM glutamate for 10 min then incubated for 24 hr with
standard medium. Cultures were pretreated with C2-ceramide for 24 hr prior to the
glutamate application. B, Dihydro-C2-¢eramide (dC2) did not affect glutamate
neurotoxicity, whereas C6-ceramide afforded neuroprotection. Cultures were exposed
to 5oo eAM glutamate for 10 min then incubated fbr 24 hr with standard medium. Cultures
were pretreated with ceramides fbr 24 hr prior to the glutarnate application. **P<O,O1,
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